tiprankstipranks
Arcutis Biotherapeutics Shines in Earnings Call
PremiumCompany AnnouncementsArcutis Biotherapeutics Shines in Earnings Call
1M ago
Strong Buy Rating for Arcutis Biotherapeutics Driven by Zoryve’s Growth and Market Expansion
Premium
Ratings
Strong Buy Rating for Arcutis Biotherapeutics Driven by Zoryve’s Growth and Market Expansion
1M ago
Arcutis Biotherapeutics price target raised to $21 from $20 at Mizuho
Premium
The Fly
Arcutis Biotherapeutics price target raised to $21 from $20 at Mizuho
1M ago
Strong Market Position and Growth Potential for Arcutis Biotherapeutics Driven by Zoryve’s Success and Strategic Initiatives
PremiumRatingsStrong Market Position and Growth Potential for Arcutis Biotherapeutics Driven by Zoryve’s Success and Strategic Initiatives
1M ago
Closing Bell Movers: Intuit up 6%, Workday up 11% on earnings
Premium
The Fly
Closing Bell Movers: Intuit up 6%, Workday up 11% on earnings
1M ago
Arcutis Biotherapeutics reports Q4 EPS (9c), consensus (26c)
Premium
The Fly
Arcutis Biotherapeutics reports Q4 EPS (9c), consensus (26c)
1M ago
Arcutis Biotherapeutics reports preliminary Q4 revenue $63M, consensus $54.95M
PremiumThe FlyArcutis Biotherapeutics reports preliminary Q4 revenue $63M, consensus $54.95M
3M ago
Arcutis Biotherapeutics price target raised to $20 from $19 at Mizuho
Premium
The Fly
Arcutis Biotherapeutics price target raised to $20 from $19 at Mizuho
3M ago
American Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
Premium
The Fly
American Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100